Immunotherapy of guinea pig cancer with BCG.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D000942:Antigens, Bacterial / Q000008:administration & dosage; D001202:Ascitic Fluid / Q000166:cytology; D001500:BCG Vaccine; D002473:Cell Wall / Q000276:immunology; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007167:Immunotherapy; D007271:Injections, Intradermal; D007275:Injections, Intravenous; D008264:Macrophages / Q000276:immunology; D051379:Mice; D008858:Microscopy, Phase-Contrast; D009161:Mycobacterium / Q000276:immunology; D009163:Mycobacterium bovis / Q000276:immunology*; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy*; D009616:Nocardia asteroides / Q000276:immunology; D011425:Propionibacterium acnes / Q000276:immunology; D012513:Sarcoma, Experimental / Q000276:immunology; D013045:Species Specificity
D000276:Adjuvants, Immunologic; D000942:Antigens, Bacterial; D001500:BCG Vaccine